Skip to main content
Caplight Logo









Cibiem, Inc.

Cibiem, Inc.

Private
New York City, New YorkHealthcare & Life Scienceshttps://cibiem.com

Last Round

Series A

Oct 17, 2012

Total Funding Raised

$42.5M

Company Overview

Cibiem, Inc. operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in October 2012.

Cibiem, Inc. is a medical device company that develops minimally invasive, catheter-based therapeutics for the treatment of sympathetic nervous system-mediated diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Cibiem, Inc. Comparables

Compare Cibiem, Inc. with similar companies based on industry and business-model similarity.

Cibiem, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cortex, Inc.
85%
Vascular Dynamics, Inc.
80%
Otsuka Holdings
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Cibiem, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 17, 2012
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Cibiem, Inc. Investors

Notable investors and investment history

Cibiem, Inc. investors
InvestorRounds
SV Health InvestorsConvertible Debt, Series B, Series A
BioStar CapitalConvertible Debt
Oxford FinanceDebt
Third Rock VenturesConvertible Debt, Series B, Series A

Cibiem, Inc. Filings

Explore SEC and related filing metadata, where available.

Cibiem, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Cibiem, Inc.'s valuation, stock price, and market status.

Is Cibiem, Inc. a public or private company?

Cibiem, Inc. is a private company.

What is the current stock price of Cibiem, Inc.?

Cibiem, Inc. is a private company, so its shares have no public market price. Caplight tracks Cibiem, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Cibiem, Inc. worth (valuation)?

Valuation information for Cibiem, Inc. is not publicly available.

Can I buy Cibiem, Inc. stock?

Cibiem, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Cibiem, Inc.'s last funding round?

Cibiem, Inc.'s most recent funding round was Series A on October 17, 2012.

Who are the main investors in Cibiem, Inc.?

Key investors in Cibiem, Inc. include SV Health Investors, Oxford Finance, Third Rock Ventures.

Will Cibiem, Inc. IPO soon?

No public IPO plans have been announced for Cibiem, Inc..

How can I track Cibiem, Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Cibiem, Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2011
Last FundingOct 17, 2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?